<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS
FILED PURSUANT TO RULES 13d-1(b) AND (c)
AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)
(Amendment No. 5 )*
MedImmune, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
584699102
------------------------------
(CUSIP Number)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
Page 1 of 14 Pages
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 2 of 14 Pages
________________________________________________________________________________
1 | NAME OF REPORTING PERSON
| S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
| HealthCare Ventures I, L.P.
________|_______________________________________________________________________
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
| (b) [ ]
________|_______________________________________________________________________
3 | SEC USE ONLY
________|_______________________________________________________________________
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
| Delaware
________|_______________________________________________________________________
| 5 | SOLE VOTING POWER
| |
|_____|__________________________________________________________
NUMBER OF | |
SHARES | 6 | SHARED VOTING POWER
BENEFICIALLY 0
OWNED BY |_____|__________________________________________________________
EACH | |
REPORTING | 7 | SOLE DISPOSITIVE POWER
PERSON WITH | |
|_____|__________________________________________________________
| |
| 8 | SHARED DISPOSITIVE POWER
| | 0
_______________|_____|__________________________________________________________
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
| 0
_______|________________________________________________________________________
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
| CERTAIN SHARES* [ ]
_______|________________________________________________________________________
11 | PERCENTAGE OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 0%
_______|________________________________________________________________________
12 | TYPE OF REPORTING PERSON*
| PN
_______|________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 3 of 14 Pages
________________________________________________________________________________
1 | NAME OF REPORTING PERSON
| S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
| HealthCare Partners I, L.P.
________|_______________________________________________________________________
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
| (b) [ ]
________|_______________________________________________________________________
3 | SEC USE ONLY
________|_______________________________________________________________________
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
| Delaware
________|_______________________________________________________________________
| 5 | SOLE VOTING POWER
| |
|_____|__________________________________________________________
NUMBER OF | |
SHARES | 6 | SHARED VOTING POWER
BENEFICIALLY 0
OWNED BY |_____|__________________________________________________________
EACH | |
REPORTING | 7 | SOLE DISPOSITIVE POWER
PERSON WITH | |
|_____|__________________________________________________________
| |
| 8 | SHARED DISPOSITIVE POWER
| | 0
_______________|_____|__________________________________________________________
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
| 0
_______|________________________________________________________________________
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
| CERTAIN SHARES* [ ]
_______|________________________________________________________________________
11 | PERCENTAGE OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 0%
_______|________________________________________________________________________
12 | TYPE OF REPORTING PERSON*
| PN
_______|________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 4 of 14 Pages
________________________________________________________________________________
1 | NAME OF REPORTING PERSON
| S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
| HealthCare Ventures II, L.P.
________|_______________________________________________________________________
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
| (b) [ ]
________|_______________________________________________________________________
3 | SEC USE ONLY
________|_______________________________________________________________________
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
| Delaware
________|_______________________________________________________________________
| 5 | SOLE VOTING POWER
| |
|_____|__________________________________________________________
NUMBER OF | |
SHARES | 6 | SHARED VOTING POWER
BENEFICIALLY 27,973
OWNED BY |_____|__________________________________________________________
EACH | |
REPORTING | 7 | SOLE DISPOSITIVE POWER
PERSON WITH | |
|_____|__________________________________________________________
| |
| 8 | SHARED DISPOSITIVE POWER
| | 27,973
_______________|_____|__________________________________________________________
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
| 27,973
_______|________________________________________________________________________
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
| CERTAIN SHARES* [ ]
_______|________________________________________________________________________
11 | PERCENTAGE OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 0.1%
_______|________________________________________________________________________
12 | TYPE OF REPORTING PERSON*
| PN
_______|________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 5 of 14 Pages
________________________________________________________________________________
1 | NAME OF REPORTING PERSON
| S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
| HealthCare Partners II, L.P.
________|_______________________________________________________________________
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
| (b) [ ]
________|_______________________________________________________________________
3 | SEC USE ONLY
________|_______________________________________________________________________
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
| Delaware
________|_______________________________________________________________________
| 5 | SOLE VOTING POWER
| |
|_____|__________________________________________________________
NUMBER OF | |
SHARES | 6 | SHARED VOTING POWER
BENEFICIALLY 27,973
OWNED BY |_____|__________________________________________________________
EACH | |
REPORTING | 7 | SOLE DISPOSITIVE POWER
PERSON WITH | |
|_____|__________________________________________________________
| |
| 8 | SHARED DISPOSITIVE POWER
| | 27,973
_______________|_____|__________________________________________________________
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
| 27,973
_______|________________________________________________________________________
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
| CERTAIN SHARES* [ ]
_______|________________________________________________________________________
11 | PERCENTAGE OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 0.1%
_______|________________________________________________________________________
12 | TYPE OF REPORTING PERSON*
| PN
_______|________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 6 of 14 Pages
________________________________________________________________________________
1 | NAME OF REPORTING PERSON
| S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
| James H. Cavanaugh, Ph.D.
________|_______________________________________________________________________
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
| (b) [ ]
________|_______________________________________________________________________
3 | SEC USE ONLY
________|_______________________________________________________________________
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
| United States
________|_______________________________________________________________________
| 5 | SOLE VOTING POWER
| | 28,765
|_____|__________________________________________________________
NUMBER OF | |
SHARES | 6 | SHARED VOTING POWER
BENEFICIALLY 27,973
OWNED BY |_____|__________________________________________________________
EACH | |
REPORTING | 7 | SOLE DISPOSITIVE POWER
PERSON WITH | | 28,765
|_____|__________________________________________________________
| |
| 8 | SHARED DISPOSITIVE POWER
| | 27,973
_______________|_____|__________________________________________________________
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
| 27,973
_______|________________________________________________________________________
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
| CERTAIN SHARES* [ ]
_______|________________________________________________________________________
11 | PERCENTAGE OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 0.2%
_______|________________________________________________________________________
12 | TYPE OF REPORTING PERSON*
| IN
_______|________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 7 of 14 Pages
________________________________________________________________________________
1 | NAME OF REPORTING PERSON
| S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
| Harold R. Werner
________|_______________________________________________________________________
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
| (b) [ ]
________|_______________________________________________________________________
3 | SEC USE ONLY
________|_______________________________________________________________________
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
| United States
________|_______________________________________________________________________
| 5 | SOLE VOTING POWER
| |
|_____|__________________________________________________________
NUMBER OF | |
SHARES | 6 | SHARED VOTING POWER
BENEFICIALLY 27,973
OWNED BY |_____|__________________________________________________________
EACH | |
REPORTING | 7 | SOLE DISPOSITIVE POWER
PERSON WITH | |
|_____|__________________________________________________________
| |
| 8 | SHARED DISPOSITIVE POWER
| | 27,973
_______________|_____|__________________________________________________________
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
| 27,973
_______|________________________________________________________________________
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
| CERTAIN SHARES* [ ]
_______|________________________________________________________________________
11 | PERCENTAGE OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 0.1%
_______|________________________________________________________________________
12 | TYPE OF REPORTING PERSON*
| IN
_______|________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 8 of 14 Pages
________________________________________________________________________________
1 | NAME OF REPORTING PERSON
| S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
| John W. Littlechild
________|_______________________________________________________________________
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
| (b) [ ]
________|_______________________________________________________________________
3 | SEC USE ONLY
________|_______________________________________________________________________
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
| United States
________|_______________________________________________________________________
| 5 | SOLE VOTING POWER
| |
|_____|__________________________________________________________
NUMBER OF | |
SHARES | 6 | SHARED VOTING POWER
BENEFICIALLY 27,973
OWNED BY |_____|__________________________________________________________
EACH | |
REPORTING | 7 | SOLE DISPOSITIVE POWER
PERSON WITH | |
|_____|__________________________________________________________
| |
| 8 | SHARED DISPOSITIVE POWER
| | 27,973
_______________|_____|__________________________________________________________
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
| 27,973
_______|________________________________________________________________________
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
| CERTAIN SHARES* [ ]
_______|________________________________________________________________________
11 | PERCENTAGE OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 0.1%
_______|________________________________________________________________________
12 | TYPE OF REPORTING PERSON*
| IN
_______|________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 9 of 14 Pages
________________________________________________________________________________
1 | NAME OF REPORTING PERSON
| S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
|
| William Crouse
________|_______________________________________________________________________
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
| (b) [ ]
________|_______________________________________________________________________
3 | SEC USE ONLY
________|_______________________________________________________________________
4 | CITIZENSHIP OR PLACE OF ORGANIZATION
| United States
________|_______________________________________________________________________
| 5 | SOLE VOTING POWER
| |
|_____|__________________________________________________________
NUMBER OF | |
SHARES | 6 | SHARED VOTING POWER
BENEFICIALLY 27,973
OWNED BY |_____|__________________________________________________________
EACH | |
REPORTING | 7 | SOLE DISPOSITIVE POWER
PERSON WITH | |
|_____|__________________________________________________________
| |
| 8 | SHARED DISPOSITIVE POWER
| | 27,973
_______________|_____|__________________________________________________________
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
| 27,973
_______|________________________________________________________________________
10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
| CERTAIN SHARES* [ ]
_______|________________________________________________________________________
11 | PERCENTAGE OF CLASS REPRESENTED BY AMOUNT IN ROW 9
| 0.1%
_______|________________________________________________________________________
12 | TYPE OF REPORTING PERSON*
| IN
_______|________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 10 of 14 Pages
________________________________________________________________________________
Item 1.
(a) Name of Issuer:
MedImmune, Inc.
(b) Address of Issuer's Principal Executive Offices:
35 West Watkins Mill Road
Gaithersburg, Maryland 20878
Item 2.
(a) Name of Person Filing:
HealthCare Ventures I, L.P. ("HCV I"), HealthCare Partners I,
L.P. ("HCP I"), HealthCare Ventures II, L.P. ("HCV II"),
HealthCare Partners II, L.P. ("HCP II"), Dr. Cavanaugh and
Messrs. Werner, Littlechild and Crouse. See attached Exhibit A
which is a copy of their agreement in writing to file this
statement on behalf of each of them.(1)
(b) Address of Principal Business Office or, if none, Residence:
The business address for HCV I, HCP I, HCV II, HCP II, Dr.
Cavanaugh, and Messrs. Werner and Crouse is 44 Nassau Street,
Princeton, New Jersey 08542. The business address for Mr.
Littlechild is One Kendall Square, Building 300, Cambridge,
Massachusetts 02139.
(c) Citizenship:
HCV I, HCP I, HCV II and HCP II are limited partnerships
organized under the laws of the State of Delaware. Dr.
Cavanaugh and Messrs. Werner, Littlechild and Crouse are each
United States citizens.
(d) Title of Class of Securities:
Common Stock, par value $.01 ("Shares").
- --------
(1) Dr. Cavanaugh and Messrs. Werner, Littlechild and Crouse are general
partners of HCP I and HCP II, which are the general partners of HCV I
and HCV II, respectively, the record holder of Issuer's securities.
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 11 of 14 Pages
________________________________________________________________________________
(e) CUSIP Number:
584699102
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or
13d-2(b), check whether the person filing is a:
Inapplicable.
Item 4. Ownership.
(a) Amount Beneficially Owned:
As of December 31, 1997: HCV I and HCP I beneficially no
Shares of the Issuer's securities; HCV II and HCP II
beneficially owned 27,973 Shares of Issuer's Common Stock;
Messrs. Werner, Littlechild and Crouse beneficially owned
27,973 Shares of Issuer's Common Stock; and Dr. Cavanaugh
beneficially owned 56,738 Shares of Issuer's Common Stock.
(b) Percent of Class:
As of December 31, 1997: the 27,973 Shares of Issuer's
securities beneficially owned by HCV II, HCP II and Messrs.
Werner, Littlechild and Crouse constitute 0.1% of Issuer's
Shares outstanding; and the 56,738 Shares of Issuer's
securities beneficially owned by Dr. Cavanaugh constitute 0.2%
of Issuer's Shares outstanding.
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
Dr. Cavanaugh has the sole power to vote or to direct
the vote of those shares owned by him.
(ii) shared power to vote or to direct the vote: HCV I,
HCP I, Dr. Cavanaugh and Messrs. Werner, Littlechild
and Crouse share the power to vote or direct the vote
of those shares owned by HCV I.
HCV II, HCP II, Dr. Cavanaugh and Messrs. Werner,
Littlechild and Crouse share the power to vote or to
direct the vote of those shares owned by HCV II.
(iii) sole power to dispose or to direct the disposition
of:
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 12 of 14 Pages
________________________________________________________________________________
Dr. Cavanaugh has the sole power to dispose or to
direct the disposition of those shares owned by him.
(iv) shared power to dispose of or to direct the
disposition of: HCV I, HCP I, Dr. Cavanaugh and
Messrs. Werner, Littlechild and Crouse share the
power to dispose of or direct the disposition of
those shares owned by HCV I.
HCV II, HCP II, Dr. Cavanaugh and Messrs. Werner,
Littlechild and Crouse share the power to dispose of
or to direct the disposition of those shares owned by
HCV II.
Item 5. Ownership of Five Percent or less of a Class:
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the Class of
Securities, check the following [X].
Item 6. Ownership of More than Five Percent on Behalf of Another
Person:
Inapplicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company:
Inapplicable.
Item 8. Identification and Classification of Members of the Group:
Inapplicable.
Item 9. Notice of Dissolution of Group:
Inapplicable.
Item 10. Certification:
Inapplicable.
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 13 of 14 Pages
________________________________________________________________________________
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: February 10, 1998 HealthCare Ventures I, L.P.,
Princeton, New Jersey by its General Partner, HealthCare
Partners I, L.P.
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 10, 1998 HealthCare Partners I, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 10, 1998 HealthCare Ventures II, L.P.,
Princeton, New Jersey by its General Partner, HealthCare
Partners II, L.P.
By: /s/ Jeffrey Steinberg
----------------------------
A General Partner
Dated: February 10, 1998 HealthCare Partners II, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-----------------------------
A General Partner
Dated: February 10, 1998 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -----------------------------
James H. Cavanaugh, Ph.D.
Dated: February 10, 1998 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -----------------------------
Harold R. Werner
Dated: February 10, 1998 By: /s/ Jeffrey Steinberg
Cambridge, Massachusetts -----------------------------
John W. Littlechild
Dated: February 10, 1998 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -----------------------------
William Crouse
<PAGE>
________________________________________________________________________________
CUSIP No. 584699102 13G Page 14 of 14 Pages
________________________________________________________________________________
EXHIBIT A
AGREEMENT
JOINT FILING OF SCHEDULE 13G
The undersigned hereby agree to jointly prepare and file with
regulatory authorities a Schedule 13G and any future amendments thereto
reporting each of the undersigned's ownership of securities of MedImmune, Inc.
and hereby affirm that such Schedule 13G is being filed on behalf of each of the
undersigned.
Dated: February 10, 1998 HealthCare Ventures I, L.P.,
Princeton, New Jersey by its General Partner, HealthCare
Partners I, L.P.
By: /s/ Jeffrey Steinberg
-------------------------------
A General Partner
Dated: February 10, 1998 HealthCare Partners I, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-------------------------------
A General Partner
Dated: February 10, 1998 HealthCare Ventures II, L.P.,
Princeton, New Jersey by its General Partner, HealthCare
Partners II, L.P.
By: /s/ Jeffrey Steinberg
-------------------------------
A General Partner
Dated: February 10, 1998 HealthCare Partners II, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-------------------------------
A General Partner
Dated: February 10, 1998 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -------------------------------
James H. Cavanaugh, Ph.D.
Dated: February 10, 1998 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -------------------------------
Harold R. Werner
Dated: February 10, 1998 By: /s/ Jeffrey Steinberg
Cambridge, Massachusetts -------------------------------
John W. Littlechild
Dated: February 10, 1998 By: /s/ Jeffrey Steinberg
Princeton, New Jersey -------------------------------
William Crouse
